dalteparin has been researched along with Papulosquamous Disorders in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
" We describe a female patient, whose localized reaction from dalteparin was followed by a generalized rash presenting as acute generalized exanthematous pustulosis." | 7.74 | Acute generalized exanthematous pustulosis from dalteparin. ( Aberer, W; Grims, R; Komericki, P; Kränke, B, 2007) |
" We describe a female patient, whose localized reaction from dalteparin was followed by a generalized rash presenting as acute generalized exanthematous pustulosis." | 3.74 | Acute generalized exanthematous pustulosis from dalteparin. ( Aberer, W; Grims, R; Komericki, P; Kränke, B, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komericki, P | 1 |
Grims, R | 1 |
Kränke, B | 1 |
Aberer, W | 1 |
1 other study available for dalteparin and Papulosquamous Disorders
Article | Year |
---|---|
Acute generalized exanthematous pustulosis from dalteparin.
Topics: Acute Disease; Anticoagulants; Dalteparin; Drug Eruptions; Exanthema; Female; Humans; Injections; Mi | 2007 |